-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
New insights on COPD imaging via CT and MRI
(2473) Views (590) Full article downloads
Authors: N Sverzellati, F Molinari, T Pirronti, L Bonomo, P Spagnolo, M Zompatori
Published Date October 2007
Volume 2007:2(3) Pages 301 - 312
DOI: http://dx.doi.org/10.2147/COPD.S
N Sverzellati1, F Molinari2, T Pirronti2, L Bonomo2, P Spagnolo3, M Zompatori1
1Institute of Radiology, Department of Clinical Sciences, University of Parma, Italy; 2Department of Bioimaging and Radiological Sciences, Catholic University of Rome, Rome, Italy; 3Clinical Genomics Group, Department of Occupational and Environmental Medicine, Imperial College of Science, London, UK
Abstract: Multidetector-row computed tomography (MDCT) can be used to quantify morphological features and investigate structure/function relationship in COPD. This approach allows a phenotypical definition of COPD patients, and might improve our understanding of disease pathogenesis and suggest new therapeutical options. In recent years, magnetic resonance imaging (MRI) has also become potentially suitable for the assessment of ventilation, perfusion and respiratory mechanics. This review focuses on the established clinical applications of CT, and novel CT and MRI techniques, which may prove valuable in evaluating the structural and functional damage in COPD.
Keywords: emphysema, computed tomography, magnetic resonance, airways, functional imaging
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




